Peter H. O'Donnell to Recurrence
This is a "connection" page, showing publications Peter H. O'Donnell has written about Recurrence.
Connection Strength
0.029
-
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Jun; 18(6):913-21.
Score: 0.020
-
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001 Dec 01; 19(23):4314-21.
Score: 0.010